Herbal Supplement Liver Toxicity

Definition

Herbal supplement liver toxicity is the risk that a familiar, “natural,” traditional, or wellness-positioned product can injure the liver because of its ingredient, concentration, dose, contamination, identity error, interaction, or use context.

Current Synthesis

Across the two sources, naturalness is not a safety test. The U.S. supplement investigation emphasizes concentrated green-tea EGCG, high-dose turmeric, label mismatch, contaminants, and weak premarket review. VOL.156 adds a China-facing clinical warning about unverified traditional medicines and the distinction between medicinal 三七 and toxic 土三七. Together they support exposure review and product identification when liver injury is suspected, without implying that all herbs or supplements are harmful.

Key Claims

• “Natural” and traditional use do not guarantee liver safety.
• Concentration, dose, ingredient identity, contamination, and product quality can all alter risk.
• A food ingredient and a concentrated extract should not be assumed to have the same exposure profile.
• Similar common names can hide materially different plants or products.
• Supplement and herbal-product use should be disclosed during evaluation of abnormal liver findings.
• Testing marks may improve identity or contamination confidence but do not prove health benefit or individual safety.

Evidence

• Concentrated extracts and label uncertainty: Why is there a supplement craze if they don’t even work? links green-tea EGCG extract, high-dose turmeric, ingredient variation, and weak premarket oversight to liver-safety concern.
• Unverified traditional products and identity confusion: VOL.156爱肝护肝第一步你就走错了 沉默的“人体化工厂”自救指南 warns about unknown herbal products and distinguishes 土三七 from 三七 in its liver-injury discussion.

Counterevidence & Qualifications

Neither source supports a blanket claim that every supplement, herb, or traditional medicine is dangerous. Product-specific causality, dose, prevalence, and clinical management require qualified assessment. The reported EGCG, turmeric, 土三七, mortality, case-share, and regulatory details remain source-scoped rather than independently verified here.

What Changed

• VOL.156 adds traditional-medicine identity confusion and clinical exposure review to the earlier supplement-regulation frame.
• The current judgment remains product-specific rather than anti-supplement or anti-herbal.

Related Concepts

• Supplement Label Accuracy - ingredient and dose mismatch can change both efficacy and toxicity.
• Third-Party Supplement Testing - verification can reduce some identity and contamination uncertainty without proving benefit.
• Dietary Supplement Regulation - oversight structure shapes how much safety evidence exists before sale.
• Targeted Supplement Need Assessment / 针对性补剂需求判断 - limits unnecessary exposure by starting from a defined need and use context.
• Silent Liver Damage Detection - explains why exposure review may matter even when pain is absent.
• Fatty Liver Cause-Directed Management - includes medicines and supplements in a broader liver-risk cause review.